Julie Beck

July 31, 2013 | Inside Counsel

In a record-making settlement, JPMorgan Chase & Co. has agreed to pay $410 million to put to bed allegations that it manipulated power markets.

By Julie Beck

2 minute read

July 30, 2013 | Inside Counsel

Though chief financial officers are feeling confident about the economy, they are not without concerns.

By Julie Beck

4 minute read

July 29, 2013 | Inside Counsel

Though the tides were looking employer-friendly when Hobby Lobby got the 10th Circuit to rule that companies have religious rights, the 3rd Circuit on Thursday signaled that the battle over the contraceptive mandate is far from over.

By Julie Beck

4 minute read

July 26, 2013 | Inside Counsel

This round of the battle over commercials goes to the consumers. And Dish Network Corp.

By Julie Beck

4 minute read

July 25, 2013 | Inside Counsel

As promised, the Food and Drug Administration (FDA) will finally allow the Plan B One-Step morning after pill to be sold to women of all ages, and will protect it from generic competition for the next three years.

By Julie Beck

4 minute read

July 24, 2013 | Inside Counsel

Pharmaceutical giant GlaxoSmithKline is in hot water in China.

By Julie Beck

2 minute read

July 23, 2013 | Inside Counsel

Employers in the 5th Circuit may have felt a chill up their spines on Wednesday, even if they didn't know why.

By Julie Beck

3 minute read

July 22, 2013 | Inside Counsel

Steven A. Cohen's hedge fund, SAC Capital Advisors, has been doing really well.

By Julie Beck

4 minute read

July 19, 2013 | Inside Counsel

Everyone has a price. But soon, doctors prices will become public knowledge.

By Julie Beck

3 minute read

July 18, 2013 | Inside Counsel

Rep. Hakeem Jeffries, D-N.Y., introduced a bill in the House last week that aims to overhaul the way courts deal with patent lawsuits.

By Julie Beck

2 minute read